Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

vacquinol-1

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Glioblastoma IV (GBM) is one of the deadliest malignant diseases in adults and is characterized by a high mutation rate and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2019
2019
AIM To investigate anti-liver fibrosis effects of Salvianolic acid B (Sal B) from Salvia miltiorrhiza Bunge involved mitogen… Expand
2019
2019
The interaction of programmed death-1 (PD-1) and it's ligands (PD-L1) is an important immune checkpoint and blockade of PD-1/PD… Expand
2019
2019
Macropinocytosis is a clathrin-independent endocytosis of extracellular fluid that may contribute to cancer aggressiveness… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2018
2018
Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor, and available experimental and routine therapies… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2018
2018
Vacquinol‑1 (Vacq), a quinolone derivative, has recently been reported to display potent antitumor effects in glioblastomas by… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2017
2017
Glioblastomas (GBM) are the most malignant brain tumors in humans and have a very poor prognosis. New therapeutic options are… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2016
2016
Glioblastoma remains an incurable brain cancer. Drugs developed in the past 20 years have not improved the prognosis for patients… Expand
2015
2015
Glioblastoma multiforme is a common form of brain tumor that leads to debilitating effects despite the current regiment of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2014
Highly Cited
2014
Glioblastoma multiforme (GBM) is the most aggressive form of brain cancer with marginal life expectancy. Based on the assumption… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6